Stay updated by reading our latest news

Kaiku Health and Oulu University Hospital have jointly published a research investigating the feasibility of machine learning in predicting symptoms of patients undergoing Immune Checkpoint Inhibitor (ICI) treatments. The study is the first of its kind and the results were published at the ESMO Immuno-Oncology Congress 2019 in Geneva on December 12. The results indicate...

The abstract to be presented at the congress is based on research conducted in collaboration between Oulu University Hospital and Kaiku Health. The research investigates a method of utilizing advanced analytics and machine learning in order to predict the onset and continuity of symptoms in patients receiving immune checkpoint inhibitor treatments. The prediction model was...

As nurses are often the primary users of digital tools such as ePRO’s in hospitals, nurse engagement is critical to their efficacious routine use. Therefore, identifying factors that promote and decrease the use of these tools among nurses is a prerequisite to their successful implementation. This whitepaper looks at the underlying factors affecting technology acceptance...

Kaiku Health has strengthened its Board of Directors with health data science and machine learning expertise as Dr. Iya Khalil joined the board in September 2019. Dr. Khalil is a recognized healthcare and life sciences technology entrepreneur and the Chief Commercial Officer and Co-Founder of GNS Healthcare, a Cambridge based data analytics company. Her machine learning...

In recent years, there has been a drastic change in the treatment landscape of several advanced cancers. Cancer immunotherapies have shown to be a viable treatment option for many patients who would have otherwise had a poor prognosis with traditional treatments, such as chemotherapy.  So far the most successful subtype of cancer immunotherapies have been...